TY  - JOUR
AU  - Peinado, Rafaela dos S.
AU  - Martins, Lucas G.
AU  - Pacca, Carolina C.
AU  - Saivish, Marielena V.
AU  - Borsatto, Kelly C.
AU  - Nogueira, Maurício L.
AU  - Tasic, Ljubica
AU  - Arni, Raghuvir K.
AU  - Eberle, Raphael J.
AU  - Coronado, Mônika A.
TI  - HR-MAS NMR Metabolomics Profile of Vero Cells under the Influence of Virus Infection and nsP2 Inhibitor: A Chikungunya Case Study
JO  - International journal of molecular sciences
VL  - 25
IS  - 3
SN  - 1422-0067
CY  - Basel
PB  - Molecular Diversity Preservation International
M1  - FZJ-2024-02999
SP  - 1414 -
PY  - 2024
AB  - Abstract: The arbovirus Chikungunya (CHIKV) is transmitted by Aedes mosquitoes in urban environments, and in humans, it triggers debilitating symptoms involving long-term complications, including arthritis and Guillain-Barré syndrome. The development of antiviral therapies is relevant, as no efficacious vaccine or drug has yet been approved for clinical application. As a detailed map of molecules underlying the viral infection can be obtained from the metabolome, we validated the metabolic signatures of Vero E6 cells prior to infection (CC), following CHIKV infection (CV) and also upon the inclusion of the nsP2 protease inhibitor wedelolactone (CWV), a coumestan which inhibits viral replication processes. The metabolome groups evidenced significant changes in the levels of lactate, myo-inositol, phosphocholine, glucose, betaine and a few specific amino acids. This study forms a preliminary basis for identifying metabolites through HR-MAS NMR (High Resolution Magic Angle Spinning Nuclear Magnetic Ressonance Spectroscopy) and proposing the affected metabolic pathways of cells following viral infection and upon incorporation of putative antiviral molecules.
LB  - PUB:(DE-HGF)16
C6  - 38338694
UR  - <Go to ISI:>//WOS:001161120400001
DO  - DOI:10.3390/ijms25031414
UR  - https://juser.fz-juelich.de/record/1025605
ER  -